we have utilized a human tumor cloning system to compare the antitumor activity of trimetrexate ( tmq ) , a new dihydrofolate reductase inhibitor , and ametantrone , a new anthracenedione , with that of analogs already in clinical trial ( methotrexate and mitoxantrone ) .
C0003174
anthracenedione
C0026259
mitoxantrone